Please login to the form below
Doina Ionescu elected to ABPI’s board of directors
Ionescu is managing director and general manager for Merck Healthcare UK and Ireland
The Association of the British Pharmaceutical Industry (ABPI) has elected Doina Ionescu, managing director and general manager for Merck Healthcare UK and Ireland, to its board of directors.
Ionescu will represent medium-sized companies on the ABPI board of directors, with aims of further strengthening the relationship between the pharma industry, patients, the NHS and the UK economy.
She began her career with Merck in 1998, working in R&D in Southampton. Since then, she has worked across various senior positions within the company including in corporate business development, life sciences and healthcare.
Prior to taking on the role of general manager for Merck Healthcare UK & ROI, she held the position of global head of business innovation.
“I feel privileged and delighted to have been elected onto the ABPI board of directors. If there was ever any doubt, last year has demonstrated the paramount importance of a strong, trusting and collaborative relationship between our industry and the wider health system,” said Ionescu.
Subscribe to our email news alerts
- Medscape Education’s Large Presence at IDWeek 2023
- WHO recommends second malaria vaccine for children
- Sanofi enters agreement with Janssen to develop E. coli vaccine candidate
- NFID and CDC urge US adults to get vaccinated against flu and COVID-19
- Man vs microbe: the fight against antimicrobial resistance
- Dollo's law
No results were found
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
- HOW TO TRANSFORM YOUR HEALTHCARE BRAND MARKETING FROM MULTI-CHANNEL TO OMNICHANNEL
- In a previous blog, we outlined the role of omnichannel in healthcare and the importance of personalised communications with the suggestion of using modular content to support an omnichannel approach....
